aluates Reports

$ 0.0

Automative

Global Lung Cancer Therapeutics Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-8N5987

Global Lung Cancer Therapeutics Market Insights Forecast to 2028

BUY CHAPTERS

Global Lung Cancer Therapeutics Market Research Report 2025

Code: QYRE-Auto-8N5987

Report

June 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Eli Lilly and Company

GlaxoSmithKline PLC

Roche

Boehringer Ingelheim GmbH

Pfizer Inc

Sanofi

Bristol–Myers Squibb

Novartis

Agennix

Lung Cancer Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Lung Cancer Therapeutics Market

The global market for Lung Cancer Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Lung Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Therapeutics.

The Lung Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lung Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Lung Cancer Therapeutics Market Report

Report Metric	Details
Report Name	Lung Cancer Therapeutics Market
CAGR	5%
Segment by Type	Targeted Therapy Immunotherapy Chemotherapy Radiation Therapy Others
Segment by Application	Non-Small Cell Lung Cancer (NSCLC) Small Cell Lung Cancer (SCLC)
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Roche, Boehringer Ingelheim GmbH, Pfizer, Sanofi S.A., Bristol-Myers Squibb, Novartis, Agennix AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lung Cancer Therapeutics Market report?

Ans: The main players in the Lung Cancer Therapeutics Market are AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Roche, Boehringer Ingelheim GmbH, Pfizer, Sanofi S.A., Bristol-Myers Squibb, Novartis, Agennix AG

What are the Application segmentation covered in the Lung Cancer Therapeutics Market report?

Ans: The Applications covered in the Lung Cancer Therapeutics Market report are Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC)

What are the Type segmentation covered in the Lung Cancer Therapeutics Market report?

Ans: The Types covered in the Lung Cancer Therapeutics Market report are Targeted Therapy, Immunotherapy, Chemotherapy, Radiation Therapy, Others

Recommended Reports

Lung and Respiratory Therapeutics

Cancer Drug Markets

Targeted Cancer Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Lung Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Targeted Therapy

1.2.3 Immunotherapy

1.2.4 Chemotherapy

1.2.5 Radiation Therapy

1.2.6 Others

1.3 Market by Application

1.3.1 Global Lung Cancer Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Non-Small Cell Lung Cancer (NSCLC)

1.3.3 Small Cell Lung Cancer (SCLC)

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Lung Cancer Therapeutics Market Perspective (2020-2031)

2.2 Global Lung Cancer Therapeutics Growth Trends by Region

2.2.1 Global Lung Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Lung Cancer Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Lung Cancer Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Lung Cancer Therapeutics Market Dynamics

2.3.1 Lung Cancer Therapeutics Industry Trends

2.3.2 Lung Cancer Therapeutics Market Drivers

2.3.3 Lung Cancer Therapeutics Market Challenges

2.3.4 Lung Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Lung Cancer Therapeutics Players by Revenue

3.1.1 Global Top Lung Cancer Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Lung Cancer Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Lung Cancer Therapeutics Revenue

3.4 Global Lung Cancer Therapeutics Market Concentration Ratio

3.4.1 Global Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapeutics Revenue in 2024

3.5 Global Key Players of Lung Cancer Therapeutics Head office and Area Served

3.6 Global Key Players of Lung Cancer Therapeutics, Product and Application

3.7 Global Key Players of Lung Cancer Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Therapeutics Breakdown Data by Type

4.1 Global Lung Cancer Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Lung Cancer Therapeutics Forecasted Market Size by Type (2026-2031)

5 Lung Cancer Therapeutics Breakdown Data by Application

5.1 Global Lung Cancer Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Lung Cancer Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Lung Cancer Therapeutics Market Size (2020-2031)

6.2 North America Lung Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Lung Cancer Therapeutics Market Size by Country (2020-2025)

6.4 North America Lung Cancer Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Lung Cancer Therapeutics Market Size (2020-2031)

7.2 Europe Lung Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Lung Cancer Therapeutics Market Size by Country (2020-2025)

7.4 Europe Lung Cancer Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Lung Cancer Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Lung Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Lung Cancer Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Lung Cancer Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Lung Cancer Therapeutics Market Size (2020-2031)

9.2 Latin America Lung Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Lung Cancer Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Lung Cancer Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Lung Cancer Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Lung Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Lung Cancer Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Lung Cancer Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Lung Cancer Therapeutics Introduction

11.1.4 AstraZeneca Revenue in Lung Cancer Therapeutics Business (2020-2025)

11.1.5 AstraZeneca Recent Development

11.2 Eli Lilly and Company

11.2.1 Eli Lilly and Company Company Details

11.2.2 Eli Lilly and Company Business Overview

11.2.3 Eli Lilly and Company Lung Cancer Therapeutics Introduction

11.2.4 Eli Lilly and Company Revenue in Lung Cancer Therapeutics Business (2020-2025)

11.2.5 Eli Lilly and Company Recent Development

11.3 GlaxoSmithKline

11.3.1 GlaxoSmithKline Company Details

11.3.2 GlaxoSmithKline Business Overview

11.3.3 GlaxoSmithKline Lung Cancer Therapeutics Introduction

11.3.4 GlaxoSmithKline Revenue in Lung Cancer Therapeutics Business (2020-2025)

11.3.5 GlaxoSmithKline Recent Development

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Lung Cancer Therapeutics Introduction

11.4.4 Roche Revenue in Lung Cancer Therapeutics Business (2020-2025)

11.4.5 Roche Recent Development

11.5 Boehringer Ingelheim GmbH

11.5.1 Boehringer Ingelheim GmbH Company Details

11.5.2 Boehringer Ingelheim GmbH Business Overview

11.5.3 Boehringer Ingelheim GmbH Lung Cancer Therapeutics Introduction

11.5.4 Boehringer Ingelheim GmbH Revenue in Lung Cancer Therapeutics Business (2020-2025)

11.5.5 Boehringer Ingelheim GmbH Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Lung Cancer Therapeutics Introduction

11.6.4 Pfizer Revenue in Lung Cancer Therapeutics Business (2020-2025)

11.6.5 Pfizer Recent Development

11.7 Sanofi S.A.

11.7.1 Sanofi S.A. Company Details

11.7.2 Sanofi S.A. Business Overview

11.7.3 Sanofi S.A. Lung Cancer Therapeutics Introduction

11.7.4 Sanofi S.A. Revenue in Lung Cancer Therapeutics Business (2020-2025)

11.7.5 Sanofi S.A. Recent Development

11.8 Bristol-Myers Squibb

11.8.1 Bristol-Myers Squibb Company Details

11.8.2 Bristol-Myers Squibb Business Overview

11.8.3 Bristol-Myers Squibb Lung Cancer Therapeutics Introduction

11.8.4 Bristol-Myers Squibb Revenue in Lung Cancer Therapeutics Business (2020-2025)

11.8.5 Bristol-Myers Squibb Recent Development

11.9 Novartis

11.9.1 Novartis Company Details

11.9.2 Novartis Business Overview

11.9.3 Novartis Lung Cancer Therapeutics Introduction

11.9.4 Novartis Revenue in Lung Cancer Therapeutics Business (2020-2025)

11.9.5 Novartis Recent Development

11.10 Agennix AG

11.10.1 Agennix AG Company Details

11.10.2 Agennix AG Business Overview

11.10.3 Agennix AG Lung Cancer Therapeutics Introduction

11.10.4 Agennix AG Revenue in Lung Cancer Therapeutics Business (2020-2025)

11.10.5 Agennix AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Eli Lilly and Company

GlaxoSmithKline PLC

Roche

Boehringer Ingelheim GmbH

Pfizer Inc

Sanofi

Bristol–Myers Squibb

Novartis

Agennix

List of Tables

Table 1. Global Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Targeted Therapy

Table 3. Key Players of Immunotherapy

Table 4. Key Players of Chemotherapy

Table 5. Key Players of Radiation Therapy

Table 6. Key Players of Others

Table 7. Global Lung Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Lung Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Lung Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Lung Cancer Therapeutics Market Share by Region (2020-2025)

Table 11. Global Lung Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Lung Cancer Therapeutics Market Share by Region (2026-2031)

Table 13. Lung Cancer Therapeutics Market Trends

Table 14. Lung Cancer Therapeutics Market Drivers

Table 15. Lung Cancer Therapeutics Market Challenges

Table 16. Lung Cancer Therapeutics Market Restraints

Table 17. Global Lung Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Lung Cancer Therapeutics Market Share by Players (2020-2025)

Table 19. Global Top Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapeutics as of 2024)

Table 20. Ranking of Global Top Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Lung Cancer Therapeutics, Headquarters and Area Served

Table 23. Global Key Players of Lung Cancer Therapeutics, Product and Application

Table 24. Global Key Players of Lung Cancer Therapeutics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Lung Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Lung Cancer Therapeutics Revenue Market Share by Type (2020-2025)

Table 28. Global Lung Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Lung Cancer Therapeutics Revenue Market Share by Type (2026-2031)

Table 30. Global Lung Cancer Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Lung Cancer Therapeutics Revenue Market Share by Application (2020-2025)

Table 32. Global Lung Cancer Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Lung Cancer Therapeutics Revenue Market Share by Application (2026-2031)

Table 34. North America Lung Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Lung Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Lung Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Lung Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Lung Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Lung Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Lung Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Lung Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Lung Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Lung Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Lung Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Lung Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Lung Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Lung Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Lung Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 49. AstraZeneca Company Details

Table 50. AstraZeneca Business Overview

Table 51. AstraZeneca Lung Cancer Therapeutics Product

Table 52. AstraZeneca Revenue in Lung Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 53. AstraZeneca Recent Development

Table 54. Eli Lilly and Company Company Details

Table 55. Eli Lilly and Company Business Overview

Table 56. Eli Lilly and Company Lung Cancer Therapeutics Product

Table 57. Eli Lilly and Company Revenue in Lung Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 58. Eli Lilly and Company Recent Development

Table 59. GlaxoSmithKline Company Details

Table 60. GlaxoSmithKline Business Overview

Table 61. GlaxoSmithKline Lung Cancer Therapeutics Product

Table 62. GlaxoSmithKline Revenue in Lung Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 63. GlaxoSmithKline Recent Development

Table 64. Roche Company Details

Table 65. Roche Business Overview

Table 66. Roche Lung Cancer Therapeutics Product

Table 67. Roche Revenue in Lung Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 68. Roche Recent Development

Table 69. Boehringer Ingelheim GmbH Company Details

Table 70. Boehringer Ingelheim GmbH Business Overview

Table 71. Boehringer Ingelheim GmbH Lung Cancer Therapeutics Product

Table 72. Boehringer Ingelheim GmbH Revenue in Lung Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 73. Boehringer Ingelheim GmbH Recent Development

Table 74. Pfizer Company Details

Table 75. Pfizer Business Overview

Table 76. Pfizer Lung Cancer Therapeutics Product

Table 77. Pfizer Revenue in Lung Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 78. Pfizer Recent Development

Table 79. Sanofi S.A. Company Details

Table 80. Sanofi S.A. Business Overview

Table 81. Sanofi S.A. Lung Cancer Therapeutics Product

Table 82. Sanofi S.A. Revenue in Lung Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 83. Sanofi S.A. Recent Development

Table 84. Bristol-Myers Squibb Company Details

Table 85. Bristol-Myers Squibb Business Overview

Table 86. Bristol-Myers Squibb Lung Cancer Therapeutics Product

Table 87. Bristol-Myers Squibb Revenue in Lung Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 88. Bristol-Myers Squibb Recent Development

Table 89. Novartis Company Details

Table 90. Novartis Business Overview

Table 91. Novartis Lung Cancer Therapeutics Product

Table 92. Novartis Revenue in Lung Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 93. Novartis Recent Development

Table 94. Agennix AG Company Details

Table 95. Agennix AG Business Overview

Table 96. Agennix AG Lung Cancer Therapeutics Product

Table 97. Agennix AG Revenue in Lung Cancer Therapeutics Business (2020-2025) & (US$ Million)

Table 98. Agennix AG Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Lung Cancer Therapeutics Picture

Figure 2. Global Lung Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lung Cancer Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Targeted Therapy Features

Figure 5. Immunotherapy Features

Figure 6. Chemotherapy Features

Figure 7. Radiation Therapy Features

Figure 8. Others Features

Figure 9. Global Lung Cancer Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Lung Cancer Therapeutics Market Share by Application: 2024 VS 2031

Figure 11. Non-Small Cell Lung Cancer (NSCLC) Case Studies

Figure 12. Small Cell Lung Cancer (SCLC) Case Studies

Figure 13. Lung Cancer Therapeutics Report Years Considered

Figure 14. Global Lung Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Lung Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Lung Cancer Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Lung Cancer Therapeutics Market Share by Players in 2024

Figure 18. Global Top Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapeutics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Lung Cancer Therapeutics Revenue in 2024

Figure 20. North America Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Lung Cancer Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Lung Cancer Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Lung Cancer Therapeutics Market Share by Region (2020-2031)

Figure 34. China Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Lung Cancer Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Lung Cancer Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Lung Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. AstraZeneca Revenue Growth Rate in Lung Cancer Therapeutics Business (2020-2025)

Figure 50. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Therapeutics Business (2020-2025)

Figure 51. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Therapeutics Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Lung Cancer Therapeutics Business (2020-2025)

Figure 53. Boehringer Ingelheim GmbH Revenue Growth Rate in Lung Cancer Therapeutics Business (2020-2025)

Figure 54. Pfizer Revenue Growth Rate in Lung Cancer Therapeutics Business (2020-2025)

Figure 55. Sanofi S.A. Revenue Growth Rate in Lung Cancer Therapeutics Business (2020-2025)

Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Lung Cancer Therapeutics Business (2020-2025)

Figure 57. Novartis Revenue Growth Rate in Lung Cancer Therapeutics Business (2020-2025)

Figure 58. Agennix AG Revenue Growth Rate in Lung Cancer Therapeutics Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Drugs for Non Small Cell Lung Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Small Cell Lung Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Treatment Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Squamous Non Small Cell Lung Cancer Therapeutics Market Research Report 2025

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Targeted Drugs for NSCLC Market Research Report 2024

Breast Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Cancer Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tumor Immunotherapy Market

Global Lung Cancer Diagnostic Tests Market Research Report 2024

Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions